UnitedHealth Group Incorporated (UNH) Stock Analysis

Research · Sep 3, 2026

[UNH] UnitedHealth Thesis 2026: Hemsley Returns to Stabilize Medicare Advantage and Optum Integration

UnitedHealth FY2025 revenue ~$435B with adj. operating margin compressed to 7.6% (from 8.7% FY2023) on Medicare Advantage MLR elevation (~85.8% vs 82% pre-COVID) + Stars rating downgrades + Change Healthcare cyberattack costs. Stephen Hemsley returned as CEO May 2025 after Witty resignation. FY2026 thesis: Hemsley operational rebuild — Stars rating recovery for FY2027 contract year, MA bid discipline raising premiums to capture elevated MLR, PBM regulatory response, Change Healthcare remediation completing; Medicare Advantage program (~$140B revenue) faces convergent regulatory pressure (Stars, MLR, payment notices, risk adjustment scrutiny); Optum vertical integration (Health/Rx/Insight) under FTC scrutiny but structurally durable.

Research · Apr 9, 2026

Medicare Advantage 2026 Rate Hike: UNH and HUM Lead Margin Winners — Ranked

The April 7, 2026, Medicare Advantage rate decision sparked gains for UNH and HUM, signaling margin relief for exposed insurers. UNH leads with balanced exposure and scale, followed by HUM's pure-play bet and CI's value. Rankings prioritize MA leverage, growth, and valuations amid stabilizing reimbursements.

Research · Mar 12, 2026

If CMS finalizes the 6.4% home health payment cut, which operators face the steepest margin compression?

Among publicly traded operators, Aveanna Healthcare (AVAH) faces the steepest margin compression from a potential 6.4% CMS home health payment cut, given its leveraged balance sheet (5.1x debt/EBITDA) and thin free cash flow ($26M), despite home health representing only ~10% of revenue. Ensign Group has minimal direct exposure as a SNF-focused operator, while Sotera Health has no home health revenue and Amedisys was acquired by UnitedHealth in 2024.